Premier Stock Price, News & Analysis

Quest Diagnostics (DGX) has secured a group purchasing agreement with Premier Inc. (PINC) for its laboratory stewardship solutions. This collaboration enables Premier members to access Quest's Lab Stewardship Enterprise at special pricing, facilitating improved healthcare delivery. The platform offers data analytics for healthcare organizations, tracking trends and identifying cost-saving opportunities. Quest aims to enhance care quality and operational efficiency as health systems face post-pandemic challenges. This agreement marks a significant enhancement in accessibility for Quest's innovative healthcare solutions.

Premier, a technology-driven healthcare improvement company listed on NASDAQ under the symbol PINC, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 8:30 a.m. ET. Interested parties can access the live audio webcast and replay on the company’s website. Premier collaborates with an alliance of over 4,400 hospitals and 250,000 healthcare providers, aiming to enhance care quality while reducing costs through data analytics, supply chain solutions, and consulting services.

Premier Inc. (NASDAQ: PINC), a technology-driven healthcare improvement company, is set to participate in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 2:35 p.m. PT (5:35 p.m. ET). A live audio webcast and a replay will be accessible on the company’s website. Premier Inc. collaborates with over 4,400 U.S. hospitals and 250,000 providers to enhance healthcare delivery through integrated data, analytics, and consulting services. For more updates, visit their news and investor site.

Premier, Inc. (NASDAQ: PINC) reported its fiscal Q1 2023 results, highlighting a 14% decline in net revenue, totaling $313.9 million, compared to the previous year. The Supply Chain Services segment saw a significant 21% decrease in revenue, attributed to normalization post-COVID-19. Conversely, Performance Services grew by 7% to $94.2 million, driven by adjacent markets. GAAP net income dropped by 65% to $42.9 million, leading to a 63% decrease in EPS. The company reaffirmed its fiscal 2023 guidance and completed an acquisition to bolster growth.

Premier, a leading healthcare improvement company, has declared a cash dividend of $0.21 per share of Class A common stock. This dividend is payable on December 15, 2022, to stockholders of record as of December 1, 2022. The company continues to play a pivotal role in enhancing healthcare delivery through integrated data and analytics, serving over 4,400 U.S. hospitals and 250,000 providers. This commitment to transformation aims to improve care quality while reducing costs.

Premier, Inc. (NASDAQ: PINC) announced that its subsidiary, Contigo Health, has finalized the acquisition of assets from TRPN Direct Pay and Devon Health. These assets include contracts with over 900,000 providers across 4.1 million locations in the U.S. The new product, Contigo Health® ConfigureNet™, aims to enhance health plan offerings while reducing costs through pre-negotiated discounts. The transaction is projected to contribute $40 million to $60 million in annual net revenue and add $0.01 to $0.02 to earnings per share in fiscal 2023.

Premier, Inc. (NASDAQ: PINC) will announce its fiscal 2023 first-quarter financial results on November 1, 2022, at 6:30 a.m. ET. A conference call to discuss the results will follow at 8:00 a.m. ET. Interested parties can access the live webcast on the company’s Investor Relations site. There will also be an option for telephone access: Domestic dial-in at (833) 953-2438 and international at (412) 317-5767.

Premier's subsidiary, Contigo Health, has announced its acquisition of assets from TRPN Direct Pay and Devon Health for $177.5 million. This deal includes contracts with over 900,000 providers across 4.1 million U.S. locations. Contigo plans to leverage these assets to enhance its ConfigureNet™ out-of-network wrap product, aiming to improve healthcare access and reduce costs for self-funded employer health plans. The transaction is expected to close in Q2 of fiscal 2023 and could generate an additional $40 million to $60 million in annual net revenue.